Zeneses Biosciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 21 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -3.49%
- Ebitda 100.00%
- Net Worth -19.89%
- Total Assets -17.63%
About Zeneses Biosciences
Zeneses Biosciences Private Limited (ZBPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 December 2003 and has a history of 21 years and two months. Its registered office is in Delhi, India.
The Corporate was formerly known as Vas Qramedies Boitec P Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vipul Goel and Sameer Goel serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239DL2003PTC123302
- Company No.
123302
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Dec 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Zeneses Biosciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sameer Goel  | Director | 05-Jul-2021 | Current |
| Vipul Goel | Director | 03-Dec-2003 | Current |
Financial Performance of Zeneses Biosciences.
Zeneses Biosciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 3.49% decrease in profit. The company's net worth observed a substantial decline by a decrease of 19.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zeneses Biosciences?
Unlock access to Zeneses Biosciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Kimia Biosciences LimitedVipul Goel and Sameer Goel are mutual person
Magnizent Biochem LlpVipul Goel and Sameer Goel are mutual person
- Biotavia Pharm Private Limited
Vipul Goel and Sameer Goel are mutual person
- Actaviaa Biotech Private Limited
Vipul Goel and Sameer Goel are mutual person
- Biowia Biotech Private Limited
Vipul Goel and Sameer Goel are mutual person
- Biotavia Labs Private Limited
Vipul Goel and Sameer Goel are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zeneses Biosciences?
Unlock and access historical data on people associated with Zeneses Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zeneses Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zeneses Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
